close

Agreements

1 2 3 4 228
Number of results: 4541

Excel print is not allowed for data more than 3000.Please search above for fewer data.

Date Company Compound Disease Type of agreement Therapeutic area Type of Information
2018-01-03 Nicox (France) nomination Ophtalmological diseases Nomination
2018-01-03 Oxford BioDynamics (UK) undisclosed major US biopharmaceutical company
  • EpiSwitch™ technology for use in the development of new predictive biomarkers for immuno-oncology therapies
  • EpiSwitch™ technology for use in the analysis of structure-function of genome architecture and new insights into fibrotic mechanisms, new targets and new biomarkers
collaboration - development Cancer - Oncology - Fibrotic diseases Collaboration agreement
2018-01-03 Anthera Pharmaceuticals (USA - CA) vice-president nomination Rare diseases - Genetic diseases Nomination
2018-01-03 Pfizer (USA - NY) Sangamo Therapeutics (USA - CA) gene therapy using zinc finger protein transcription factors (ZFP-TFs) gene therapy using zinc finger protein transcription factors (ZFP-TFs) development Rare diseases - Genetic diseases - Neurodegenerative diseases Development agreement
2018-01-02 PharmaMar (Spain) Megapharm (Israel) Aplidin® (plitidepsin) multiple myeloma licensing - commercialisation - distribution Cancer - Oncology Licensing agreement
2018-01-02 LogicBio Therapeutics (USA - MA)
  • chief business officer - vice president -  clinical and regulatory strategist
nomination Rare diseases - Genetic diseases Nomination
2017-12-27 Shire (UK - USA) plasma manufacturing facility in Covington validation of a production plant Rare diseases - Genetic diseases - Hematological diseases Validation of a production plant
2017-12-27 Kazia Therapeutics (Australia), previously known as Novogen - Noxopharm (Australia) NOX66 (idronoxil) collaboration Cancer - Oncology Collaboration agreement
2017-12-26 Vivus (USA - CA) chief executive officer nomination Resignation
2017-12-26 HTG Molecular Diagnostics (USA - AZ) Merck KGaA (Germany) companion diagnostic development Cancer - Oncology Collaboration agreement
2017-12-26 Peregrine Pharmaceuticals (USA - CA) presdient - chief executive officer nomination Cancer - Oncology Nomination
2017-12-22 Roche (Switzerland) Accenture (Ireland) digital data integration services services contract Technology - Services - Cancer - Oncology Services contract
2017-12-22 Formycon (Germany) Aristo Pharma (Germany) FYB202 GmbH & Co (Germany) FYB202 - biosimilar version of ustekinumab - biosimilar ustekinumab joint-venture Autoimmune diseases – Inflammatory diseases - Rheumatic diseases - Dermatological diseases - Digestive diseases Joint-venture agreement
2017-12-22 Antisense Therapeutics (Australia) myTomorrows (The Netherlands) ATL1103 - atesidorsen acromegaly collaboration Rare diseases - Hormonal diseases - Endocrine diseases Collaboration agreement
2017-12-21 immatics biotechnologies (Germany) Roche (Switzerland) tumour-associated peptide (TUMAP)-based cancer vaccine (including IMA942) and other cancer immunotherapies gastric cancer, prostate cancer, non-small cell lung cancer R&D - research - development - commercialisation Cancer - Oncology Exercise of an option agreement
2017-12-21 Zealand Pharma (Denmark) Beta Bionics (USA - MA) dual hormonal artificial, or bionic, pancreas system - dual-hormone bionic pancreas utilizing both dasiglucagon (liquid formulation glucagon analog) and insulin diabetes development - collaboration Metabolic diseases Development agreement
2017-12-21 Janssen Biotech, a J&J company (USA - NJ) Legend Biotech USA and Legend Biotech, subsidiaries of Genscript Biotech Corporation (China) LCAR-B38M multiple myeloma licensing - development - production - commercialisation Cancer - Oncology Licensing agreement
2017-12-21 Theradiag (France) MSD France (France) LISA TRACKER® kits for the monitoring of Remicade® services contract Autoimmune diseases – Inflammatory diseases - Rheumatic diseases - Dermatological diseases - Digestive diseases Services contract
2017-12-21 Crispr Therapeutics (Switzerland - UK) chairman of the board of directors nomination Rare diseases - Genetic diseases - Hematological diseases Nomination
2017-12-21 LFB (France) chief executive officer nomination Rare diseases - Genetic diseases - Hematological diseases Nomination